Stay updated on Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition to using “Super Intelligence” instead of “Artificial Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T19:17:29.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer site revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T19:12:30.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1, while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T20:11:47.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The study record page shows a 403 Forbidden message with a link back to Home, and the trial details are unavailable.
    Difference
    0.6%
    Check dated 2026-10-03T19:48:40.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the study record details, indicating restricted access rather than a content update.
    Difference
    18%
    Check dated 2026-09-19T18:36:54.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision label on the page updated from Revision: v3.6.5 to Revision: v3.6.6, indicating a minor system update. The change does not modify study details, eligibility criteria, or other substantive content on the page.
    Difference
    0.1%
    Check dated 2026-08-29T18:33:07.000Z thumbnail image

Stay in the know with updates to Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.